ClaytonBiotech

Pipeline

Research programs of Clayton Foundation and its supporting organizations have led to several FDA approved drugs, medical devices and diagnostic assays along with the following pipeline in development by our licensees. We also have technologies and preclinical projects that are available for licensing.

Available for Licensing
(Pre-Clinical & Early Stage)

DHS Fc Domain

Fc domain for antibody half-life extension

NHP POC 

HI P. Goldsteinii

Indication: Osteoporosis and Obesity

Preclinical (Download PDF)

Cyspondin

LGR Targeting Protein Drug Conjugate

Preclinical

HDAC Inhibitors for TB

Valproic acid to treat TB

Drug Repurposing (Download PDF)

Partnered (Pre-Clinical & Clinical)

ArboShield - DV

Biological (insect) vaccination for Dengue

ArboShield - ZK

Biological (insect) vaccination for Zika

ArboShield - CV

Biological (insect) vaccination for Chikungunya

RT-200

Indication: Type II Diabetes

Phase 1/2a planned

 

 

Scroll to Top